Greek registry aims to map hidden genetic cholesterol disorder
NCT ID NCT03140605
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study creates a registry for people with familial hypercholesterolemia (FH) in Greece, a genetic condition that causes very high cholesterol and early heart disease. Researchers will screen adults aged 18 to 80 to learn how common FH is and describe the health of those affected. The goal is to gather information, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide a clearer picture of how common familial hypercholesterolemia is in Greece and help guide future screening and treatment efforts.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any therapy, so its impact depends on how the data is used afterward.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2017
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Sample of citizents on Panhellenic basis
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * both genders * \>18 years, \<80 years * door to door enrolment * eligible to sign informed consent Exclusion Criteria: * \<18 years, \>80 years * deny to sign informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Familial hypercholesterolemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Onassis Cardiology Hospital
Athens, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new multi-test approach may spot hidden blood vessel damage before symptoms appear
- Which contact method best warns families of hidden cholesterol danger?
- Are cholesterol patients getting the right care? new study aims to find out
- 15,000 kids to be screened for hidden heart disease genes
- Heart attack patients under 60 get genetic screening for hidden cholesterol disorder
- Should doctors call your family? study tests best way to screen for genetic risks